SCHEMBL3435660

SCHEMBL3435660

CCC(O)Cc1nc(Nc2cc(F)cc(OC)c2)nn1-c1ccnc(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 4/20 0.37
▸ KDR P35968 2/20 0.35
▸ FLT1 P17948 1/20 0.35
▸ FLT4 P35916 1/20 0.35
▸ MAPK1 P28482 3/20 0.34
▸ PTK2 Q05397 2/20 0.34
▸ KCNH3 Q9ULD8 3/20 0.33
▸ GSK3B P49841 3/20 0.33
▸ CDK2 P24941 2/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ SYK P43405 3/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ ZAP70 P43403 2/20 0.32
▸ SRC P12931 1/20 0.32
▸ MUSK O15146 1/20 0.32
▸ NTRK1 P04629 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3783059 1.00 JAK2 (0.37) JAK2KDRFLT1FLT4MAPK1
SCHEMBL3776106 0.90 SRC (0.33) MAPK1LMNATP53ZAP70SRC
SCHEMBL3435554 0.90 SRC (0.33) MAPK1LMNATP53ZAP70SRC
SCHEMBL3777850 0.89 GSK3B (0.46) JAK2KDRFLT1FLT4GSK3B
SCHEMBL8018216 0.89 GSK3B (0.46) JAK2KDRFLT1FLT4GSK3B
SCHEMBL3434426 0.85 MAPK1 (0.33) JAK2MAPK1GSK3BCDK2CDK4
SCHEMBL3781770 0.85 MAPK1 (0.33) JAK2MAPK1GSK3BCDK2CDK4
SCHEMBL3779354 0.80 SRC (0.33) MAPK1LMNASRC
SCHEMBL3781782 0.78 MAPK1 (0.33) MAPK1CDK2CDK4P2RX7
SCHEMBL3030101 0.78 JAK2 (0.42) JAK2KDRFLT1FLT4PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257535-A1 TRISUBSTITUTED 1, 2, 4 -TRIAZOIIES AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2010-12-08 — — EP disclosed
WO-2009115547-A1 TRISUBSTITUTED 1, 2, 4 -TRIAZOIIES AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2009-09-24 — — WO disclosed
Send feedback